Top Drug Discovery and Development Companies In Canada
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Drug Discovery and Development Companies In Canada
Drug Discovery and Development News
Drug Discovery and Development Evolve through Artificial Intelligence and Precision Medicine
Monday, August 31, 2026
Drug discovery and development is one of the most significant fields of healthcare and life sciences today. The acceleration of therapeutic innovation, enhancement of clinical outcome and reduction in developmental timeline in a variety of diseases is the focus of many pharmaceutical and biotech companies and research institutions to leverage the use of novel technologies and databased research. This field covers target discovery, molecular screening, biologics development, preclinical investigation, clinical trials management, and regulatory approval. The global drug discovery and development market continues to grow steadily as chronic disease rates rise, precision medicine ex
Collaborative Drug Discovery Partners with Lilly TuneLab to Make Lilly AI/ML Models Available in CDD Vault
Thursday, May 21, 2026
BURLINGAME, Calif., May 20, 2026 /PRNewswire/ -- Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault. Lilly TuneLab was created by Lilly to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly's proprietary research data. Through this agreement, biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific work
Advancing Drug Development Innovation in Canada
Tuesday, April 14, 2026
Fremont, CA: Pharmaceutical labs are increasingly leveraging advanced technologies to reshape drug development, bringing precision and speed to a field long marked by lengthy timelines. Advanced analytics, AI-driven modeling, and automated screening help researchers identify promising compounds faster, while collaborations across biotech startups and global institutions accelerate innovation. These breakthroughs improve the efficiency of drug pipelines and enhance the safety and efficacy of therapies reaching patients, signaling a shift toward more targeted, patient-centered solutions in medicine. How Does Drug Development Improve Patient Outcomes?
Advancing Conservation and Ecology Through Environmental DNA
Friday, April 10, 2026
FREMONT, CA: Environmental DNA, or eDNA, is transforming the fields of ecology and conservation biology. Increasingly, scientists are turning to this innovative technology to monitor biodiversity and assess ecosystem health. By analyzing genetic material found in environmental samples—such as soil, water, or air—researchers can identify species in a given area without the need for direct observation or capture. The advent of environmental DNA (eDNA) as a powerful research tool has revolutionized conservation and ecological studies, offering diverse applications across multiple domains. One of its primary uses is in species detection and monitori
Advancing Clinical-Stage Biopharmaceutical Development with Biomarkers
Monday, March 02, 2026
FREMONT CA: Biomarkers—biological indicators of specific physiological or pathological states—have revolutionized drug development and personalized medicine. In the fast-expanding biopharmaceutical research landscape of the Asia-Pacific (APAC) region, they play a vital role in optimizing clinical trials, improving patient outcomes, and accelerating the creation of innovative therapies. Understanding Biomarkers and Their Role in Clinical-Stage Biopharmaceutical Research Biomarkers, categorized into diagnostic, prognostic, predictive, and surrogate types, play a crucial role in modern medicine. Diagnostic biomarkers iden
